Home » Archive

News

Marketwire, News, Syndication »

Ardea Biosciences Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock

Posted by Mary Canady February 6th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Feb 6, 2012) – Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced the completion of an underwritten public offering of 9,775,000 shares of its common stock, including 1,275,000 shares sold pursuant to the full exerci…

More...

News, Syndication, Xconomy »

FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects

Posted by sandiegobiotech February 6th, 2012 .
No Comments

If you’ve turned on your TV anytime in the last, oh, decade or so, you’ve no doubt been bombarded by ads imploring you to “ask your doctor” about Drug X. And you’re well familiar with the routine:…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy

Posted by sandiegobiotech February 3rd, 2012 .
No Comments

—San Diego’s Amylin Pharmaceuticals says Bydureon, its new once-a-week drug for treating Type 2 diabetes can hit the market as early as next month, after the FDA cleared Bydureon. The FDA rejected…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

Quidel to Hold Fourth Quarter and Full Year 2011 Financial Results Conference Call on February 29, 2012

Posted by Mary Canady February 2nd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Feb 2, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release fourth quarter and full year 2011 financial results after market…

More...

Marketwire, News, Syndication »

Quidel to Hold Fourth Quarter and Full Year 2011 Financial Results Conference Call on February 29, 2012

Posted by Mary Canady February 2nd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Feb 2, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release fourth quarter and full year 2011 financial results after market…

More...

Marketwire, News, Syndication »

Quidel to Hold Fourth Quarter and Full Year 2011 Financial Results Conference Call on February 29, 2012

Posted by Mary Canady February 2nd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Feb 2, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release fourth quarter and full year 2011 financial results after market…

More...

Marketwire, News, Syndication »

Quidel to Hold Fourth Quarter and Full Year 2011 Financial Results Conference Call on February 29, 2012

Posted by Mary Canady February 2nd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Feb 2, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release fourth quarter and full year 2011 financial results after market…

More...

News, Syndication, Xconomy »

San Diego Life Sciences Strengthened in Recession, Outpacing Nation

Posted by sandiegobiotech February 1st, 2012 .
No Comments

Employment in San Diego’s life sciences sector grew by 15 percent over the past two years, as biopharmas, medical device companies, and other employers added roughly 5,550 jobs here—raising…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

Ardea Biosciences Prices Public Offering of Common Stock

Posted by Mary Canady February 1st, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Feb 1, 2012) – Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced the pricing of an underwritten public offering of 8,500,000 shares of its common stock, offered at a price to the public of $17.00 per share. The gros…

More...

News, Syndication, Xconomy »

Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says

Posted by sandiegobiotech February 1st, 2012 .
No Comments

Bonnie Ramsey said three years ago that a cystic fibrosis drug from Vertex Pharmaceuticals was a huge medical advance in the making, and would end up being an achievement on par with putting a man on…

[[Click headline to continue reading.]]

More...